News

Published on 30 Mar 2024 on GuruFocus.com via Yahoo Finance

Chief Legal Officer Deborah Miller Sells 22,000 Shares of Nuvalent Inc (NUVL)


Article preview image

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted therapies for patients with cancer, has reported an insider sale according to a recent SEC filing. Chief Legal Officer Deborah Miller sold 22,000 shares of the company on March 28, 2024. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.Over the past year, the insider has sold a total of 83,578 shares of Nuvalent Inc (NASDAQ:NUVL) and has not made any insider purchases. The recent sale by the insider was executed at a stock price of $75.2, valuing the transaction at $1,654,400. Following this transaction, Nuvalent Inc (NASDAQ:NUVL) has a market capitalization of $4.81 billion.The insider transaction history for Nuvalent Inc (NASDAQ:NUVL) over the past year indicates a trend of insider sales, with a total of 37 recorded insider sells and no insider buys during the same period.

Chief Legal Officer Deborah Miller Sells 22,000 Shares of Nuvalent Inc (NUVL)Chief Legal Officer Deborah Miller Sells 22,000 Shares of Nuvalent Inc (NUVL)

The data provided reflects the transactions of the insider and does not necessarily indicate the company's performance or insider's view on the company's future prospects. Investors often consider insider selling and buying patterns as part of their analysis, but it is important to look at the overall context and not to rely solely on such transactions when making investment decisions.

NASDAQ.NUVL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Nuvalent, Inc. (NUVL): Short Seller Sentiment is Bearish on This Cancer Stock

We recently compiled a list of the 10 Worst Cancer Stocks To Buy Now According to Short Sellers. ...

Insider Monkey · via Yahoo Finance 22 Sep 2024

Nuvalent, Inc. (NUVL): Among Hedge Funds’ Top Biotech Stock Picks

We recently compiled a list of the 10 Largest Biotech Hedge Funds and Their Top Stock Picks. In t...

Insider Monkey · via Yahoo Finance 22 Sep 2024

Why Earnings Season Could Be Great for Nuvalent (NUVL)

Investors are always looking for stocks that are poised to beat at earnings season and Nuvalent, ...

Zacks via Yahoo Finance 6 May 2024

Chief Legal Officer Deborah Miller Sells 3,000 Shares of Nuvalent Inc (NUVL)

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted thera...

GuruFocus.com via Yahoo Finance 5 Apr 2024

Biotech ripe for ‘cascade of dealmaking’ - Here are the top companies to watch

Few corners of the market have been as prone to dealmaking over the last couple of years as the l...

Investing.com 4 Apr 2024

Nuvalent director Matthew Shair sells over $2.8 million in company stock

Nuvalent, Inc. ( NASDAQ :NUVL) Director Matthew Shair has recently sold a significant amount of t...

Investing.com 2 Apr 2024

Chief Legal Officer Deborah Miller Sells 22,000 Shares of Nuvalent Inc (NUVL)

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted thera...

GuruFocus.com via Yahoo Finance 30 Mar 2024

Chief Development Officer Darlene Noci Sells 20,000 Shares of Nuvalent Inc (NUVL)

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted thera...

GuruFocus.com via Yahoo Finance 25 Mar 2024

Director Emily Conley Sells 13,333 Shares of Nuvalent Inc (NUVL)

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted thera...

GuruFocus.com via Yahoo Finance 19 Mar 2024

Nuvalent advances cancer drug trials, maintains strong cash position By Investing.com

Nuvalent advances cancer drug trials, maintains strong cash position

Investing.com 27 Feb 2024